Showing results (1791-1800 of 1,878) with videos related to
Sort By:
Pageof 188
Cell|June 2, 2018
Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical NeurogenesisIan T Fiddes, Gerrald A Lodewijk, Meghan Mooring, et al.Blood Cancer Journal|August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohortsPatrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.Nature|October 9, 2024
Temporally distinct 3D multi-omic dynamics in the developing human brainMatthew G Heffel, Jingtian Zhou, Yi Zhang, et al.Cell|March 15, 2024
Type-I-interferon-responsive microglia shape cortical development and behaviorCaroline C Escoubas, Leah C Dorman, Phi T Nguyen, et al.Cell Stem Cell|February 21, 2024
Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disordersDavid Shin, Chang N Kim, Jayden Ross, et al.Nature Neuroscience|December 3, 2024
Implementation and validation of single-cell genomics experiments in neuroscienceMarco Colonna, Genevieve Konopka, Shane A Liddelow, et al.Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCLKerstin Wenzl, Matt Stokes, Joseph P Novak, et al.Oncotarget|April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to deliveryAlan H Bryce, Jan B Egan, Mitesh J Borad, et al.Blood Cancer Journal|June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCLKerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.Blood Advances|September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent eraSanjal H Desai, Michael A Spinner, Andrew M Evens, et al.Pageof 188